Vignolo PaulinaX

E-posters (5)

Economic evaluation of proximal intestinal mucosal ablation in insulin-requiring type 2 diabetes: cost-effectiveness and price threshold analysis from a UK NHS perspective with comparison to semaglutide

First-in-human study of proximal intestinal mucosal ablation (PIMA) for the treatment of inadequately controlled type 2 diabetes

Evaluating Proximal Intestinal Mucosal Ablation as a Repeat Endoscopic Therapy for Type 2 Diabetes

Procedural Learning Curve For Proximal Intestinal Mucosal Ablation (PIMA) Using A Novel Through-The-Scope Radiofrequency Vapor Ablation Catheter

Proximal intestinal mucosal ablation (PIMA) enables discontinuation of exogenous insulin in type 2 diabetes: final results from the STEAM-IE trial